Cryoport, Inc.
Cryoport, Inc. (CYRX) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CYRX · as of Sep 30, 2025
Ownership Breakdown
171
Institutional Holders
$444.14M
Total Inst. Value
▲ $99.38M vs Q2
50.40M
Shares Outstanding
freeFloat 80.77%
46.85M
13F Shares Held
▲ 640,771 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CYRX largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
CADIAN CAPITAL MANAGEMENT, LP pharmaceutical preparations | 4.98M | 9.95% | 9.95% | $47.25B | Nov 14, 2025 | ▲ 14.8K |
MORGAN STANLEY pharmaceutical preparations | 4.61M | 9.20% | 9.20% | $43.71B | May 27, 2026 | ▲ 36.9K |
BLACKROCK, INC. pharmaceutical preparations | 4.00M | 7.98% | 7.98% | $37.90B | Nov 12, 2025 | ▼ 121.0K |
VANGUARD GROUP INC pharmaceutical preparations | 2.86M | 5.70% | 5.70% | $27.09B | Nov 7, 2025 | ▲ 69.5K |
BROWN CAPITAL MANAGEMENT LLC pharmaceutical preparations | 2.62M | 5.23% | 5.23% | $24.86B | Nov 4, 2025 | ▼ 1.18M |
MILLENNIUM MANAGEMENT LLC pharmaceutical preparations | 2.62M | 5.23% | 5.23% | $24.85B | Nov 14, 2025 | ▲ 408.3K |
FRED ALGER MANAGEMENT, LLC pharmaceutical preparations | 1.78M | 3.55% | 3.55% | $16.88B | Nov 14, 2025 | ▼ 578.4K |
THEMATICS ASSET MANAGEMENT pharmaceutical preparations | 1.64M | 3.27% | 3.27% | $15.53B | Nov 14, 2025 | ▼ 276.3K |
ASSENAGON ASSET MANAGEMENT S.A. pharmaceutical preparations | 1.50M | 2.99% | 2.99% | $14.21B | Oct 7, 2025 | ▲ 408.3K |
UBS GROUP AG pharmaceutical preparations | 1.33M | 2.66% | 2.66% | $12.62B | Nov 13, 2025 | ▲ 705.6K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
29
Increased
+4.07M shares4
New Positions
first time holders14
Decreased
−2.57M shares0
Sold Out
fully exitedNet shares change (top 50)
+1.50M
+4.07M / −2.57M
Net new holders
+19
4 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CYRX insider trading · insider activity
Source: SEC Form 4
Insiders have been primarily selling shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
2
Buy transactions
2
Sell transactions
1.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
STEFANOVICH ROBERT Chief Financial Officer | Mar 23, 2026 | Sale | 1,094 | $8.18 | $8.9K | 279.3K | Form 4 ↗ |
SHELTON JERRELL President, CEO | Mar 23, 2026 | Sale | 2,894 | $8.18 | $23.7K | 1.05M | Form 4 ↗ |
Sawicki Mark W Chief Scientific Officer | Mar 23, 2026 | Sale | 1,341 | $8.18 | $11.0K | 102.4K | Form 4 ↗ |
ZECCHINI EDWARD J See Remarks | Mar 14, 2026 | Award | 21,322 | — | — | 111.7K | Form 4 ↗ |
ZECCHINI EDWARD J See Remarks | Mar 16, 2026 | Sale | 2,014 | $8.00 | $16.1K | 109.7K | Form 4 ↗ |
ZECCHINI EDWARD J See Remarks | Mar 14, 2026 | Award | 63,965 | $8.60 | $550.1K | 64.0K | Form 4 ↗ |
SHELTON JERRELL President, CEO | Mar 16, 2026 | Sale | 7,918 | $8.00 | $63.3K | 1.05M | Form 4 ↗ |
SHELTON JERRELL President, CEO | Mar 14, 2026 | Award | 492,901 | $8.60 | $4.24M | 492.9K | Form 4 ↗ |
Sawicki Mark W Chief Scientific Officer | Mar 14, 2026 | Award | 22,845 | — | — | 106.9K | Form 4 ↗ |
Sawicki Mark W Chief Scientific Officer | Mar 16, 2026 | Sale | 3,235 | $8.00 | $25.9K | 103.7K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Cryoport, Inc. (CYRX) is primarily owned by institutional investors, who hold approximately 93.0% of total shares outstanding. Company insiders own approximately 19.23%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Cryoport, Inc. is CADIAN CAPITAL MANAGEMENT, LP, holding approximately 4.98 million shares — equal to 9.95% of outstanding shares — as of September 30, 2025.
A total of 171 institutional investors currently hold CYRX stock, with a combined institutional value of approximately $444,141,222 as of the most recent 13F filing period.
Frequently asked questions
CYRX ownershipCryoport, Inc. (CYRX) is primarily owned by institutional investors, who hold approximately 93.0% of shares. The largest shareholder is CADIAN CAPITAL MANAGEMENT, LP with a 9.95% stake. Company insiders hold 19.23%. Data sourced from SEC Form 13F as of September 30, 2025.